CEFZIL Drug Patent Profile
✉ Email this page to a colleague
When do Cefzil patents expire, and when can generic versions of Cefzil launch?
Cefzil is a drug marketed by Corden Pharma and is included in two NDAs.
The generic ingredient in CEFZIL is cefprozil. There are thirteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefzil
A generic version of CEFZIL was approved as cefprozil by CHARTWELL RX on November 14th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFZIL?
- What are the global sales for CEFZIL?
- What is Average Wholesale Price for CEFZIL?
Summary for CEFZIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 12 |
| Patent Applications: | 6,191 |
| DailyMed Link: | CEFZIL at DailyMed |
Recent Clinical Trials for CEFZIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ranbaxy Laboratories Limited | N/A |
| Teva Pharmaceuticals USA | Phase 1 |
| Sandoz | Phase 1 |
US Patents and Regulatory Information for CEFZIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corden Pharma | CEFZIL | cefprozil | FOR SUSPENSION;ORAL | 050665-001 | Dec 23, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Corden Pharma | CEFZIL | cefprozil | TABLET;ORAL | 050664-002 | Dec 23, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Corden Pharma | CEFZIL | cefprozil | FOR SUSPENSION;ORAL | 050665-002 | Dec 23, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Corden Pharma | CEFZIL | cefprozil | TABLET;ORAL | 050664-001 | Dec 23, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
